Trexquant Investment LP Neu Base Therapeutics, Inc. Transaction History

Trexquant Investment LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$3.27 - $4.76 $62,882 - $91,534	-19,230 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$4.63 - $7.34 $89,034 - $141,148	19,230 New	19,230 $92,000
Q1 2021 May 13, 2021	SELL	$6.92 - $12.36 $107,114 - $191,320	-15,479 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$6.92 - $9.25 $107,114 - $143,180	15,479 New	15,479 $108,000

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.